Skip to content
Menu
INFECTIOUS ECONOMICS | by Blythe Adamson
  • Methods
    • Research
    • Course
  • Publications
    • Manuscripts
    • Abstracts
    • Other Articles
  • Teaching
  • Press
  • About
INFECTIOUS ECONOMICS | by Blythe Adamson

About

Blythe Adamson, PhD, MPH

Infectious disease epidemiologist and economist accelerating the development of valuable drugs, vaccines, and public health policy

Where I work: I am Affiliate Professor at the University of Washington in The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, Director of Quantitative Sciences at Flatiron Health in New York City, and COVID-19 Advisor at Testing for America. As a consultant, I generate evidence and advise governments, industry, and non-profit organizations through Infectious Economics, LLC. 

What I do: To inform decisions I compare the effectiveness of treatments and interventions, mathematically model disease progression and transmission, analyze electronic health records and wearable data, design healthcare resource allocation strategies, and develop novel research methods using natural language processing and machine learning. Business Insider recently recognized me as one of the Top 30 Leaders Transforming Healthcare.

Tools and skills: Coding in R, Python, C++, Stata, and more, I use methods including dynamic transmission modeling, Markov, decision trees, agent-based microsimulation, natural language processing, and machine learning for causal inference, forecasting, and decision-making.

Experience: I was a researcher for over a decade at the HIV Vaccine Trials Network, based at the Fred Hutchinson Cancer Research Center in Seattle. I have designed and built mathematical models for Boston Scientific, the Institute for Disease Modeling, Intellectual Ventures, and the Patient-Centered Outcomes Research Institute (PCORI). I co-founded SmartDx, an award-winning infectious disease diagnostic platform to support clinical decision-making with predictive patient risk factors and real-time big-data analytics. I was past global chair of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) student network, where I led >5,000 PhD students in 37 countries, equipped 110 presidents of university chapters, and facilitated 10 committees to strengthen the next generation of health economists.

Training: I have a PhD in pharmaceutical science and health economics from The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute at the University of Washington, advised by Professor Emeritus Louis Garrison, and a masters in public health (MPH) in epidemiology, advised by Drs. James Kublin and Peter Gilbert at the University of Washington.

Learn more

  • Follow @InfectiousEcon and @DrBlytheAdamson
  • Publications and Google Scholar profile
  • Press, honors and awards
  • LinkedIn, short resume, or long resume
Blythe Adamson, PhD, MPH, author of Infectious Economics

High resolution headshot alternative – download here

Contact me

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSave

SaveSaveSaveSave

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)

Top Posts & Pages

  • About
    About
  • Course
    Course
  • CHEAT SHEET: Cancer Immunotherapy
    CHEAT SHEET: Cancer Immunotherapy
  • Press
    Press
  • Press: ACA Medicaid expansion eliminated racial disparities in timely cancer treatment
    Press: ACA Medicaid expansion eliminated racial disparities in timely cancer treatment
  • Manuscripts
    Manuscripts
  • The Atlantic: People v. Cancer
    The Atlantic: People v. Cancer
My Tweets
Twitter
©2021 INFECTIOUS ECONOMICS | by Blythe Adamson | Powered by WordPress and Superb Themes!